Literature DB >> 8027498

Mite allergen exposure is a risk for the incidence of specific sensitization.

J Kuehr1, T Frischer, R Meinert, R Barth, J Forster, S Schraub, R Urbanek, W Karmaus.   

Abstract

BACKGROUND: Mite allergen exposure is essential for the process of specific allergic sensitization. However, it is not clear whether incidence of specific sensitization at school age depends on the level of mite antigen exposure. Therefore the relationship between mite allergen exposure and incidence of specific sensitization was investigated.
METHODS: Eighteen hundred twelve primary school children were enrolled in a population-based 2-year follow-up study. In three consecutive skin prick tests (SPTs), each 12 months apart, sensitization to Dermatophagoides pteronyssinus (Dpt) and six non-Dpt allergens was ascertained. To assess exposure to Der p I between the first and second SPTs (period I) and the second and third SPTs (period II), the amount of antigen per gram of dust (taken from the children's mattresses was measured. By using the SPT reactions to Dpt as a basis, conversions after "no wheal" were classified as doubtful incidence (average yearly incidence = 6.7%) or definite incidence (average yearly incidence = 3.2%). Then, with the use of multiple logistic regression, the risk of exposure to Der p I (medians: 1.4 micrograms/gm in period I, 1.6 micrograms/gm in period II) was analyzed with adjustment being made for gender, low gestational age, parental atopy, and initial sensitization to non-Dpt allergens.
RESULTS: Regarding doubtful incidence, the analysis failed to identify a reliable cutoff point of exposure. For definite incidence, the Der p I exposure represents a significant risk in the total population, starting from a concentration of 9 micrograms/gm. This effect is modified by an initial sensitization to non-Dpt allergens: for these children exposure to concentrations above 2 micrograms/gm poses a significant risk, whereas for the population without other initial sensitizations, only an extremely high cutoff limit (> 80 micrograms/gm) gains significance.
CONCLUSION: Our data suggest that a concentration limit of 2 micrograms Der p I antigen per gram of dust should be regarded as minimal avoidance level for primary prevention in children with sensitization to other inhalant allergens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027498     DOI: 10.1016/0091-6749(94)90070-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  36 in total

Review 1.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 2.  Allergen exposure and the development of asthma.

Authors:  R Sporik; T A Platts-Mills
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 3.  Clinical effects of allergen avoidance.

Authors:  A Custovic; A Woodcock
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

Review 4.  Environmental causes of asthma in inner city children. The National Cooperative Inner City Asthma Study.

Authors:  P A Eggleston
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

5.  Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study.

Authors:  L H M Rijssenbeek-Nouwens; A J Oosting; M S de Bruin-Weller; I Bregman; J G R de Monchy; D S Postma
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

6.  Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children.

Authors:  C S Murray; G Poletti; T Kebadze; J Morris; A Woodcock; S L Johnston; A Custovic
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

7.  Environmental assessment and exposure control of dust mites: a practice parameter.

Authors:  Jay Portnoy; Jeffrey D Miller; P Brock Williams; Ginger L Chew; J David Miller; Fares Zaitoun; Wanda Phipatanakul; Kevin Kennedy; Charles Barnes; Carl Grimes; Désirée Larenas-Linnemann; James Sublett; David Bernstein; Joann Blessing-Moore; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace
Journal:  Ann Allergy Asthma Immunol       Date:  2013-12       Impact factor: 6.347

Review 8.  Allergen avoidance in the treatment of asthma and atopic disorders.

Authors:  A Custovic; A Simpson; M D Chapman; A Woodcock
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

9.  Atopy and house dust mite sensitization as risk factors for asthma in children.

Authors:  Jung-Wook Shin; Ju-Hee Sue; Tae-Won Song; Kyung-Won Kim; Eun-Soo Kim; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

10.  Messages from the Aalst Allergy Study.

Authors:  Dirk Van Gysel; Elke Govaere; Katia M C Verhamme; Erenik Doli; Frans De Baets
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.